Shuichi Mizuta

6PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersTraditional Chinese medicine and treatmentsCancer therapy (excl. chemotherapy and radiation therapy)Transplantation immunologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 27, 2025
Potential of Orally Administered Quercetin, Hesperidin, and p-Coumaric Acid in Suppressing Intra-/Extracellular Advanced Glycation End-Product-Induced Cytotoxicity in Proximal Tubular Epithelial Cells.

Takanobu Takata, Junji Moriya, Katsuhito Miyazawa

|Sep 27, 2025
Potential of Natural Products in Hangeshashinto Water Extract on the Direct Suppression of Stomatitis Induced by Intra-/Extracellular Advanced Glycation End-Products.

Takanobu Takata, Junji Moriya, Katsuhito Miyazawa

|Jun 24, 2022
A Case Report on Dysgraphia in a Patient Receiving Blinatumomab: Complex Characters Are Easy to Find in a Handwriting Test.

Yasuto Yamamoto, Takeo Shimasaki, Yasuhito Ishigaki

|May 10, 2022
Propensity score matching/reweighting analysis comparing autologous and allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.

Shuichi Mizuta, Tomotaka Ugai, Harumi Kato

|May 31, 2018
Plasma concentrations of dasatinib have a clinical impact on the frequency of dasatinib dose reduction and interruption in chronic myeloid leukemia: an analysis of the DARIA 01 study.

Shuichi Mizuta, Masashi Sawa, Hisashi Tsurumi

|Oct 07, 2017
Improved prognosis with additional medium-dose VP16 to CY/TBI in allogeneic transplantation for high risk ALL in adults.

Yasuyuki Arai, Tadakazu Kondo, Akio Shigematsu

Pageof 1

Frequent Collaborators

2 joint publications

Takanobu Takata

2 joint publications

Katsuhito Miyazawa

2 joint publications

Shinya Inoue

2 joint publications

Sohsuke Yamada